PCN106 Development of a Guidance for Including Patient-Reported Outcomes (PROs) in Late-Phase Adult Clinical Trials of Oncology Drugs for Comparative Effectiveness Research (CER)
Abstract
Authors
E.M. Basch A.P. Abernethy C.D. Mullins M.R. Spencer